DE69838300D1 - Pharmazeutische suspensionstabletten-zusammenstellungen - Google Patents

Pharmazeutische suspensionstabletten-zusammenstellungen

Info

Publication number
DE69838300D1
DE69838300D1 DE69838300T DE69838300T DE69838300D1 DE 69838300 D1 DE69838300 D1 DE 69838300D1 DE 69838300 T DE69838300 T DE 69838300T DE 69838300 T DE69838300 T DE 69838300T DE 69838300 D1 DE69838300 D1 DE 69838300D1
Authority
DE
Germany
Prior art keywords
percent
tablets
microcrystalline cellulose
tablet compositions
pharmaceutical suspension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69838300T
Other languages
English (en)
Other versions
DE69838300T2 (de
Inventor
Michael Augello
Sheila M Dell
George A Agyilirah
George E Reier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FMC Corp
Original Assignee
FMC Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FMC Corp filed Critical FMC Corp
Application granted granted Critical
Publication of DE69838300D1 publication Critical patent/DE69838300D1/de
Publication of DE69838300T2 publication Critical patent/DE69838300T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
DE69838300T 1997-12-12 1998-11-20 Pharmazeutische suspensionstabletten-zusammenstellungen Expired - Fee Related DE69838300T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/989,787 US5955107A (en) 1997-12-12 1997-12-12 Pharmaceutical suspension tablet compositions
US989787 1997-12-12
PCT/US1998/024798 WO1999030689A1 (en) 1997-12-12 1998-11-20 Pharmaceutical suspension tablet compositions

Publications (2)

Publication Number Publication Date
DE69838300D1 true DE69838300D1 (de) 2007-10-04
DE69838300T2 DE69838300T2 (de) 2008-05-15

Family

ID=25535456

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69838300T Expired - Fee Related DE69838300T2 (de) 1997-12-12 1998-11-20 Pharmazeutische suspensionstabletten-zusammenstellungen

Country Status (7)

Country Link
US (1) US5955107A (de)
EP (1) EP1035838B1 (de)
AT (1) ATE370727T1 (de)
AU (1) AU1531199A (de)
DE (1) DE69838300T2 (de)
ES (1) ES2293694T3 (de)
WO (1) WO1999030689A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
CA2328703C (en) * 1998-06-11 2007-10-30 Pharmacia & Upjohn Company Delavirdine tablet formulation
US6358060B2 (en) 1998-09-03 2002-03-19 Jsr Llc Two-stage transmucosal medicine delivery system for symptom relief
US6344222B1 (en) 1998-09-03 2002-02-05 Jsr Llc Medicated chewing gum delivery system for nicotine
US6432448B1 (en) * 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
UY26615A1 (es) * 2000-03-16 2001-10-25 Pfizer Prod Inc Inhibidor de la glucogeno fosforilasa.
AU2001261744A1 (en) * 2000-05-19 2001-12-03 Npd Llc Chewing gums, lozenges, candies, tablets, liquids, and sprays for efficient delivery of medications and dietary supplements
US6544552B2 (en) 2001-01-11 2003-04-08 Particle And Coating Technologies, Inc. Method of producing porous tablets with improved dissolution properties
MXPA04007169A (es) * 2002-01-25 2004-10-29 Santarus Inc Suministro transmucosal de inhibidores de bomba de protones.
JP2005517690A (ja) * 2002-02-01 2005-06-16 ファイザー・プロダクツ・インク 固体薬物分散物を含有する即時放出剤形
EA200500213A1 (ru) * 2002-07-16 2005-08-25 Рэнбакси Лабораториз Лимитед Диспергируемые таблетки для орального назначения
AU2003247023A1 (en) * 2002-08-02 2004-02-25 Ranbaxy Laboratories Limited A process for the preparation of dispersible tablet of cephalexin
US20040109889A1 (en) 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
US20040161459A1 (en) * 2002-12-31 2004-08-19 Ngoc Do Fast-dissolve tablet technology
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US7838029B1 (en) * 2003-07-31 2010-11-23 Watson Laboratories, Inc. Mirtazapine solid dosage forms
US7390503B1 (en) 2003-08-22 2008-06-24 Barr Laboratories, Inc. Ondansetron orally disintegrating tablets
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
JP2009527504A (ja) * 2006-02-23 2009-07-30 イオメディックス スリープ インターナショナル エスアールエル 良質な睡眠の誘導および維持のための組成物および方法
US8642016B2 (en) 2006-07-21 2014-02-04 Jsrnti, Llc Medicinal delivery system, and related methods
AU2010300641B2 (en) 2009-09-30 2016-03-17 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse
RU2673818C2 (ru) 2012-11-30 2018-11-30 Экьюра Фармасьютикалз, Инк. Саморегулируемое высвобождение фармацевтического ингредиента
US10500226B2 (en) 2012-12-30 2019-12-10 Hadasit Medical Research Services And Development Ltd. Alginate compositions and uses thereof
EP3122337A4 (de) 2014-03-26 2017-11-08 Sun Pharma Advanced Research Company Ltd Missbrauchssichere feste darreichungsform mit unmittelbarer freisetzung und beschichtetem reservoir
WO2017040607A1 (en) 2015-08-31 2017-03-09 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient
WO2023101951A1 (en) * 2021-12-03 2023-06-08 Hercules Llc An organic chewable composition comprising certified organic ingredients, and process for preparing the same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7084587A (en) * 1986-04-01 1987-10-20 Upjohn Company, The Methylprednisolone/sodium carboxymethyl starch tablet composition
US5073377A (en) * 1988-11-03 1991-12-17 Miles Inc. Method of preparing oral dosage forms with a granulating composition
US4965072A (en) * 1988-11-03 1990-10-23 Miles Inc. Granulating composition and method
SK282071B6 (sk) * 1991-01-30 2001-10-08 The Wellcome Foundation Limited Tableta dispergovateľná vo vode a spôsob jej prípravy
US5370878A (en) * 1993-09-30 1994-12-06 Hallmark Pharmaceuticals, Inc. Method for preparing a direct compression granulated acetaminophen composition
US5605889A (en) * 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin
MX9704079A (es) * 1994-12-01 1997-12-31 Cibus Pharmaceutical Inc Liberacion de farmacos antiinflamatorios no esteroides empleando uan goam hidrocoloide en polvo que se obtiene de plantas superiores.
GB9603699D0 (en) * 1996-02-21 1996-04-17 Boots Co Plc Therapeutic composition
US5858409A (en) * 1996-04-17 1999-01-12 Fmc Corporation Hydrolyzed cellulose granulations for pharmaceuticals

Also Published As

Publication number Publication date
ES2293694T3 (es) 2008-03-16
EP1035838A4 (de) 2006-01-18
DE69838300T2 (de) 2008-05-15
AU1531199A (en) 1999-07-05
EP1035838A1 (de) 2000-09-20
EP1035838B1 (de) 2007-08-22
US5955107A (en) 1999-09-21
ATE370727T1 (de) 2007-09-15
WO1999030689A1 (en) 1999-06-24

Similar Documents

Publication Publication Date Title
DE69838300D1 (de) Pharmazeutische suspensionstabletten-zusammenstellungen
EA200000246A1 (ru) Быстро дезинтегрирующие таблетки метилцеллюлозы
ATE209898T1 (de) Feste arzneizubereitung
ATE215816T1 (de) Feste oral anzuwendende arzeneiform
NO20065390L (no) Farmasoytisk preparat i fast enhetsdoseringsform
FI20011852A (fi) Menetelmä fluoksetiinia tai sen happoadditiosuolaa sisältävän dispergoituvan tabletin valmistamiseksi
MY129234A (en) Oral pharmaceutical forms of administration with a delayed action with tramadol.
NZ507566A (en) Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants
ATE424810T1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
HUP0004383A3 (en) Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient
NZ322053A (en) Controlled release pharmaceutical formulation comprising an active, a low MW polyethylene oxide, HPMC and one or more enteric polymers
EA200000245A1 (ru) Быстро дезинтегрирующие таблетки метилцеллюлозы
DE60120648D1 (de) Formulierungen von copolymer 1 (glatirameracetat) zur oralen, nasalen und pulmonalen verabreichung
MY104010A (en) Pharmaceutical compositions.
CA2330480A1 (en) Controlled release formulation of divalproex sodium
DE60038536D1 (de) Matrixsystem mit verzögerter freisetzung für hochlösliche wirkstoffe
RU96116411A (ru) Быстро распадающаяся готовая препаративная форма трамадола или соли трамадола
CA2383212A1 (en) Controlled release oral dosage suitable for oral administration
HUP9801241A2 (hu) Vastagbélbe beadható, azathioprine tartalmú készítmények és eljárás előállításukra
BR0117147A (pt) preparado de dosagem oral de desintegração instantánea
SE8901003L (sv) Snabbloesliga preparat
EA200401418A1 (ru) Способ получения таблеток из фармацевтически активных веществ, имеющих неблагоприятные свойства для таблетирования, с использованием гранулирующей жидкости, содержащей микрокристаллическую целлюлозу
YU47044B (sh) Postupak za dobijanje tableta sa produženim delovanjem na bazi hidroksipropil-metilceluloze velike molekularne mase
HUP9903410A2 (hu) Tolfenámsavat vagy gyógyszerészetileg elfogadható sóját tartalmazó, gyors hatóanyag-leadású tabletta
CA2255064A1 (en) Potassium, sodium and tris oxaprozin salt pharmaceutical formulations

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee